Acadia Pharmaceuticals

Acadia Pharmaceuticals is a biopharmaceutical company. It focuses on the development and commercialization of drugs to address unmet medical needs in central nervous system (CNS) disorders. The company's products include Nuplazid, which is used to treat hallucinations and delusions associated with Parkinson’s disease psychosis.